Return On Equity ratio Analysis of Pfizer Inc - Deep Dive


Latest FY ROE
Period Ending - Dec-24

8.68


Not Good ROE
Period Ending - Dec-23
2.42

Poor ROE
Growth
259.00 %
Trailing Twelve Months ROE
Period Ending - Dec-24

11.95


Indecisive ROE
Most recent Quarter ROE
Period Ending - Jun-25

3.27


Indecisive ROE
ROE Analysis of Pfizer Inc
ROE Ratio of PFE rose handsomely by 259.00 % this year.
ROE Ratio with value of 32.74 was highest in Year Dec-22 in last Five Years.
ROE Ratio with value of 2.42 was lowest in Year Dec-23 in last Five Years.
Latest ROE Ratio with value of 8.68 is lower than Average ROE of 17.50 in last five years.
Other ROE Related Info of PFE that may interest you.
Pfizer Inc Overview
CodePricePrevious PricePrice ChangeSector
PFE24.7624.670.365 % Drug Manufacturers-General
Fundamental AnalysisTechnical Analysis
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund.   more ..
Return On Equity Formula

ROE Related Ratios
ReturnOnAssetNetProfitMargin

Tsr Profitability Index
No Significant Profitability
FY - Historical Return On Equity of Pfizer Inc
PeriodDec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18
ROE8.682.4232.7428.4315.2125.6917.59
Change259.00 %-92.62 %15.16 %86.98 %-40.82 %46.07 %-41.14 %
You are view first 7 Records. Log in to view all 40 in Premium view
FY Chart of Return On Equity of Pfizer Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)